Twist Bioscience Corporation Common Stock
TWST Real Time Price USDRecent trades of TWST by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by TWST's directors and management
* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.
- 1M
- 3M
- 6M
- YTD
- 1Y
- 2Y
- 5Y
- MAX
About
Key Metrics
Return (1d)
Return (30d)
Return (1Y)
CAGR (Total)
Max Drawdown
Beta
Alpha
Sharpe Ratio
Win Rate
Average Win
Average Loss
Annual Volatility
Annual Std Dev
Information Ratio
Treynor Ratio
Total Trades
Metrics Definitions
-
Alpha
Measures a portfolio's risk-adjusted performance against that of its benchmark
Learn More -
Annual Standard Deviation
Measures how much the portfolio's total return varies from its mean or average.
Learn More -
Annual Volatility
A statistical measure of the dispersion of returns for the portfolio.
Learn More -
Average Win
The average return (%) for trades that resulted in a positive return.
-
Average Loss
The average return (%) for trades that resulted in a negative return.
-
Beta
A measure of the volatility of the portfolio compared to the market as a whole.
Learn More -
CAGR
CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.
Learn More -
Information Ratio
A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.
Learn More -
Max Drawdown
the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.
Learn More -
Sharpe Ratio
The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.
Learn More -
Total Trades
The total number of trades made by this strategy.
-
Treynor Ratio
Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.
Learn More -
Win Rate
The percentage of total trades that resulted in a positive return.
Be the first to see our newest insights and key updates across all datasets.
Government lobbying spending instances
-
$75,000 Apr 17, 2025 Issue: Health Issues Intelligence Copyright/Patent/Trademark Tariff (miscellaneous tariff bills)
-
$46,500 Jan 26, 2025 Issue: Health Issues Intelligence Copyright/Patent/Trademark
-
$46,500 Oct 17, 2024 Issue: Copyright/Patent/Trademark Intelligence Health Issues Budget/Appropriations
-
$46,000 Jul 21, 2024 Issue: Copyright/Patent/Trademark Intelligence Health Issues Budget/Appropriations
-
$46,000 Apr 15, 2024 Issue: Copyright/Patent/Trademark Intelligence Health Issues Budget/Appropriations
-
$43,500 Feb 02, 2024 Issue: Medical/Disease Research/Clinical Labs Health Issues Budget/Appropriations
-
$43,500 Oct 16, 2023 Issue: Health Issues Budget/Appropriations
-
$43,500 Jul 10, 2023 Issue: Health Issues Budget/Appropriations
-
$12,500 Jan 03, 2023 Issue: Science/Technology
-
$12,500 Oct 17, 2022 Issue: Science/Technology
-
$25,000 Jul 19, 2022 Issue: Science/Technology
-
$30,525 Apr 20, 2022 Issue: Science/Technology
-
$30,525 Jan 19, 2022 Issue: Science/Technology Defense
-
$30,525 Oct 20, 2021 Issue: Science/Technology
-
$30,525 Jul 16, 2021 Issue: Science/Technology Budget/Appropriations
-
$30,500 Apr 15, 2021 Issue: Science/Technology
-
$30,500 Jan 19, 2021 Issue: Science/Technology Budget/Appropriations
-
$30,000 Oct 20, 2020 Issue: Budget/Appropriations Science/Technology
-
$30,000 Jul 20, 2020 Issue: Budget/Appropriations Medical/Disease Research/Clinical Labs Science/Technology
-
$30,000 Apr 17, 2020 Issue: Budget/Appropriations Medical/Disease Research/Clinical Labs Science/Technology
-
$30,000 Jan 15, 2020 Issue: Science/Technology
Estimated quarterly lobbying spending
TWST Revenue by Segment or Geography
New patents grants
-
Patent Title: Methods for seamless nucleic acid assembly Apr. 08, 2025
-
Patent Title: Antibodies that bind cd3 epsilon Mar. 25, 2025
-
Patent Title: Methods and compositions relating to adenosine receptors Jan. 21, 2025
-
Patent Title: Methods and compositions relating to covid antibody epitopes Jan. 21, 2025
-
Patent Title: Antibodies that bind cd3 epsilon Dec. 24, 2024
-
Patent Title: Dickkopf-1 variant antibodies and methods of use Nov. 05, 2024
-
Patent Title: Variant nucleic acid libraries for crth2 Sep. 17, 2024
-
Patent Title: Dna-based digital information storage with sidewall electrodes Sep. 10, 2024
-
Patent Title: Nucleic acid based data storage Aug. 06, 2024
-
Patent Title: Variant nucleic acid libraries for coronavirus Jun. 25, 2024
-
Patent Title: Methods of synthesizing oligonucleotides using tethered nucleotides Apr. 30, 2024
-
Patent Title: Oligonucleic acid variant libraries and synthesis thereof Nov. 07, 2023
-
Patent Title: Heated nanowells for polynucleotide synthesis Sep. 05, 2023
-
Patent Title: Polynucleotides, reagents, and methods for nucleic acid hybridization Aug. 22, 2023
-
Patent Title: Devices and methods for oligonucleic acid library synthesis Jul. 04, 2023
-
Patent Title: Nucleic acid based data storage Jan. 24, 2023
-
Patent Title: De novo synthesized gene libraries Jan. 24, 2023
-
Patent Title: Nucleic acid based data storage using enzymatic bioencryption Jan. 10, 2023
-
Patent Title: Flexible substrates for nucleic acid synthesis Nov. 29, 2022
-
Patent Title: Variant nucleic acid libraries for antibody optimization Nov. 08, 2022
-
Patent Title: Variant nucleic acid libraries for glp1 receptor Nov. 08, 2022
-
Patent Title: Polynucleotides, reagents, and methods for nucleic acid hybridization Nov. 08, 2022
-
Patent Title: De novo synthesized gene libraries Sep. 27, 2022
-
Patent Title: Gpcr binding proteins and synthesis thereof Aug. 09, 2022
-
Patent Title: Methods for seamless nucleic acid assembly Jul. 05, 2022
-
Patent Title: Methods for seamless nucleic acid assembly May. 17, 2022
-
Patent Title: Barcode-based nucleic acid sequence assembly May. 17, 2022
-
Patent Title: Nucleic acid based data storage Mar. 01, 2022
-
Patent Title: De novo synthesized gene libraries Nov. 30, 2021
-
Patent Title: Functionalized surfaces and preparation thereof Apr. 27, 2021
-
Patent Title: De novo synthesized nucleic acid libraries Apr. 13, 2021
-
Patent Title: Dna-based digital information storage with sidewall electrodes Mar. 02, 2021
-
Patent Title: Variant libraries of the immunological synapse and synthesis thereof Feb. 02, 2021
-
Patent Title: Variant libraries of the immunological synapse and synthesis thereof Jan. 19, 2021
-
Patent Title: Heated nanowells for polynucleotide synthesis Jan. 19, 2021
-
Patent Title: Oligonucleic acid variant libraries and synthesis thereof Nov. 24, 2020
-
Patent Title: De novo synthesized gene libraries Sep. 15, 2020
-
Patent Title: Nucleic acid based data storage Aug. 25, 2020
-
Patent Title: Devices and methods for oligonucleic acid library synthesis Aug. 18, 2020
-
Patent Title: Methods for seamless nucleic acid assembly Jun. 30, 2020
-
Patent Title: Methods and devices for de novo oligonucleic acid assembly Jun. 02, 2020
-
Patent Title: De novo synthesized gene libraries May. 05, 2020
-
Patent Title: De novo synthesized gene libraries Mar. 10, 2020
-
Patent Title: Nucleic acid based data storage Sep. 17, 2019
-
Patent Title: Functionalized surfaces and preparation thereof Aug. 20, 2019
-
Patent Title: De novo synthesized gene libraries Aug. 20, 2019
-
Patent Title: De novo synthesized gene libraries Apr. 30, 2019
-
Patent Title: De novo synthesized nucleic acid libraries Aug. 21, 2018
-
Patent Title: Devices and methods for oligonucleic acid library synthesis May. 29, 2018
-
Patent Title: Functionalized surfaces and preparation thereof Feb. 20, 2018
Federal grants, loans, and purchases
- $12,206 2025-06-03 00:00:00 Agency: Department of Health and Human Services
- $22,735 2024-08-28 00:00:00 Agency: Department of Health and Human Services
- $21,578 2024-08-23 00:00:00 Agency: Department of Health and Human Services
- $150,000 2024-08-19 00:00:00 Agency: Department of Veterans Affairs
- $14,031 2024-08-14 00:00:00 Agency: Department of Health and Human Services
- $15,117 2024-08-12 00:00:00 Agency: Department of Health and Human Services
- $157,390 2024-07-25 00:00:00 Agency: Department of Health and Human Services
- $22,400 2024-07-17 00:00:00 Agency: Department of Health and Human Services
- $32,070 2024-07-10 00:00:00 Agency: Department of Veterans Affairs
- $24,285 2024-01-31 00:00:00 Agency: Department of Health and Human Services
- $47,888 2023-09-26 00:00:00 Agency: Department of Veterans Affairs
- $51,160 2023-08-25 00:00:00 Agency: Department of Health and Human Services
- $14,407 2023-07-29 00:00:00 Agency: Department of Health and Human Services
- $77,874 2023-07-06 00:00:00 Agency: Department of Health and Human Services
- $14,999 2022-09-22 00:00:00 Agency: DEPARTMENT OF HEALTH AND HUMAN SERVICES (HHS)
- $60,000 2022-09-08 00:00:00 Agency: DEPARTMENT OF HEALTH AND HUMAN SERVICES (HHS)
- $25,578 2022-05-05 00:00:00 Agency: None
- $14,283 2022-03-24 00:00:00 Agency: DEPARTMENT OF HEALTH AND HUMAN SERVICES (HHS)
- $11,635 2022-02-02 00:00:00 Agency: DEPARTMENT OF HEALTH AND HUMAN SERVICES (HHS)
- $2,720,000 2021-11-10 00:00:00 Agency: DEPARTMENT OF HEALTH AND HUMAN SERVICES (HHS)
- $578,225 2021-03-11 00:00:00 Agency: DEPARTMENT OF HEALTH AND HUMAN SERVICES (HHS)
- $363,755 2021-02-04 00:00:00 Agency: DEPARTMENT OF HEALTH AND HUMAN SERVICES (HHS)
Estimated quarterly amount awarded from public contracts
Recent insights relating to TWST
Recent picks made for TWST stock on CNBC
ETFs with the largest estimated holdings in TWST
- ... Highest Price Target
- ... Median Price Target
- ... Lowest Price Target
|
Analyst
|
Firm
|
Current
|
Previous
|
Date
|
|---|
- Is $TWST stock a Buy, Sell, or Hold?
- What is the price target for $TWST stock?
* Analyst consensus is not financial advice. Please see our data disclaimers .
|
Shareholder
|
Shares Held
|
|---|
- Who owns $TWST stock?
- Who owns the most shares of $TWST stock?
- What funds own $TWST stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view TWST Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.